U.S. Nuclear Medicine Market Size, Share, Analysis, By Type (Diagnostic Radiopharmaceuticals {PET Radiopharmaceuticals [FDG-PET/18F, 68Ga, 68Cu, 11C, and Others] and SPECT Radiopharmaceuticals [Technetium-99m, Iodine-123, Xenon-133, Thallium-201, and Others]}, and Therapeutic Radiopharmaceuticals), By Application (Neurology, Cardiology, Oncology, and Others), By End-user (Hospitals & Clinics, Diagnostic Centers, and Others), and Country Forecast, 2024-2032

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI109233

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

Schedule a 30 minutes session to understand our consulting capabilities – SCHEDULE NOW

Table of Content

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, Key Players
2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
3. Overview of Regulatory Scenario
4. Impact of Covid-19 on the Market
5. Pipeline Analysis
U.S. Nuclear Medicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic Radiopharmaceuticals
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic Radiopharmaceuticals
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles
  1. Lantheus
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Cardinal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Bracco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. GE HealthCare (General Electric Company)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. CURIUM
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. Bayer AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. RLS, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Advanced Accelerator Applications (Novartis AG)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. Nordion (Canada) Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. Jubilant Pharma Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Introduction
1. Research Scope
2. Market Segmentation
3. Research Methodology
4. Definitions and Assumptions
Executive Summary
Market Dynamics
1. Market Drivers
2. Market Restraints
3. Market Opportunities
4. Market Trends
Key Insights
1. New Product Launches, Key Players
2. Key Industry Developments - Mergers, Acquisitions, and Partnerships
3. Overview of Regulatory Scenario
4. Impact of Covid-19 on the Market
5. Pipeline Analysis
U.S. Nuclear Medicine Market Analysis, Insights and Forecast, 2019-2032
1. Market Analysis, Insights and Forecast – By Type
  1. Diagnostic Radiopharmaceuticals
    1. PET Radiopharmaceuticals
      1. FDG-PET/18F
      2. 68Ga
      3. 68Cu
      4. 11C
      5. Others
    2. SPECT Radiopharmaceuticals
      1. Technetium-99m
      2. Iodine-123
      3. Xenon-133
      4. Thallium-201
      5. Others
  2. Therapeutic Radiopharmaceuticals
2. Market Analysis, Insights and Forecast – By Application
  1. Neurology
  2. Cardiology
  3. Oncology
  4. Others
3. Market Analysis, Insights and Forecast – By End-user
  1. Hospitals & Clinics
  2. Diagnostic Centers
  3. Others
Competitive Analysis
1. U.S. Market Share Analysis (2023)
2. Company Profiles
  1. Lantheus
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  2. Cardinal Health
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  3. Bracco
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  4. GE HealthCare (General Electric Company)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  5. CURIUM
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  6. Bayer AG
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  7. RLS, Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  8. Advanced Accelerator Applications (Novartis AG)
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  9. Nordion (Canada) Inc.
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)
  10. Jubilant Pharma Limited
    1. Overview
    2. Products
    3. SWOT Analysis
    4. Recent Developments
    5. Strategies
    6. financials (Based on Availability)

Read Less

List of Figures

Table 01: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, By Type, 2019–2032

Table 02: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, Diagnostic Radiopharmaceuticals, 2019–2032

Table 03: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, PET Radiopharmaceuticals, 2019–2032

Table 04: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, SPECT Radiopharmaceuticals, 2019–2032

Table 05: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, By Application, 2019–2032

Table 06: U.S. Nuclear Medicine Market Revenue (USD billion) Forecast, By End-user, 2019–2032

List of Tables

Figure 01: U.S. Nuclear Medicine Market Revenue Breakdown (USD billion, %), By Type, 2024 & 2032

Figure 02: U.S. Nuclear Medicine Market Value Share (%), By Type, 2024 & 2032

Figure 03: U.S. Nuclear Medicine Market Value Share (%), By Application, 2024 & 2032

Figure 04: U.S. Nuclear Medicine Market Value Share (%), By End-user, 2024 & 2032

Figure 05: U.S. Nuclear Medicine Market Share Analysis (%), By Company, 2023

STUDY PERIOD: 2019-2032
BASE YEAR: 2023
HISTORICAL DATA: 2019-2022
NO OF PAGES: 70

Buy Now

Download Free Sample

Security Code

Growth Advisory Services

Clients

Related Reports

Get In Touch With Us

US +1 833 909 2966 ( Toll Free )

UK +44 808 502 0280 ( Toll Free )

+91 744 740 1245 (APAC)
sales@fortunebusinessinsights.com